Literature DB >> 1652567

p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia.

J Bártková1, J Bártek, J Lukás, B Vojtĕsek, Z Stasková, A Rejthar, J Kovarík, C A Midgley, D P Lane.   

Abstract

Expression of the p53 oncoprotein was examined in a wide range of primary human testicular germ-cell tumours using a new mouse monoclonal antibody (MAb) BP53-11 raised and characterized in this study, in parallel with a polyclonal rabbit antiserum CM-1. Immunohistochemistry on paraffin sections showed positive nuclear reaction in at least a fraction of malignant cells in 90 (84%) out of 107 cases studied. Aberrant accumulation of the p53 protein was found among testicular tumours of all major histological types, although generally a higher percentage of positive cases and a higher proportion of p53 over-expressing nuclei within individual lesions was observed in embryonal carcinomas when compared with seminomas. The typical heterogeneous staining pattern characteristic of histological specimens was also found in a cultured cell line derived from a human embryonal carcinoma. In contrast to immunohistochemically undetectable levels in normal testes and morphologically normal tissue areas in the tumour-bearing testes, the accumulation of the p53 protein was clearly identified in a high proportion (59% of cases) of the pre-invasive lesions with positive atypical intratubular germ cells often found in the tissue adjacent to invasive tumours. Altered expression of the p53 protein is therefore a unifying feature of the majority of invasive male germ-cell tumours and the change resulting in high levels of p53 appears to be a relatively early step in the human testicular cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652567     DOI: 10.1002/ijc.2910490209

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Biological markers of cisplatin resistance in advanced testicular germ cell tumours.

Authors:  Adelaida García-Velasco; Ignacio Durán; Elena García; Miquel Tarón; Claudio Ballestín; Daniel Castellanos; Hernán Cortés-Funés; Luis Paz-Ares
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

Review 2.  Germline genome protection: implications for gamete quality and germ cell tumorigenesis.

Authors:  J C Bloom; A R Loehr; J C Schimenti; R S Weiss
Journal:  Andrology       Date:  2019-05-22       Impact factor: 3.842

3.  p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells.

Authors:  D B Zamble; T Jacks; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

5.  Lysine methylation represses p53 activity in teratocarcinoma cancer cells.

Authors:  Jiajun Zhu; Zhixun Dou; Morgan A Sammons; Arnold J Levine; Shelley L Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-17       Impact factor: 11.205

6.  Germ cell tumors of the testis overexpress wild-type p53.

Authors:  L Guillou; A Estreicher; P Chaubert; J Hurlimann; A M Kurt; G Metthez; R Iggo; A C Gray; P Jichlinski; H J Leisinger; J Benhattar
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

7.  Low p53 protein expression in salivary gland tumours compared with lung carcinomas.

Authors:  Y Soini; D Kamel; K Nuorva; D P Lane; K Vähäkangas; P Pääkkö
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers.

Authors:  Luis A Hidalgo Grau; Josep M Badia; Carmen Admella Salvador; Teresa Soler Monsó; Josep Feliu Canaleta; Josep M Gubern Nogués; Javier Suñol Sala
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

9.  p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions.

Authors:  D Kamel; Y Soini; K Nuorva; A Khalifa; A Mangoud; K Vähäkangas; P Pääkkö
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas.

Authors:  Y Soini; P Pääkkö; K Nuorva; D Kamel; D P Lane; K Vähäkangas
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.